Cyclooxygenase-2 expression in the hereditary mixed polyposis syndrome

Digestive Diseases and Sciences

Volumn 49, Issue 11-12, 2004, Pages 1906-1911

  Brazowski, Eli ^a   Misonzhnick Bedny, Faina ^a   Rozen, Paul ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Chemoprevention; Colorectal cancer; COX 2; Familial polyps

Indexed keywords

CYCLOOXYGENASE 2;

ADULT; ARTICLE; CANCER PREVENTION; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; COLON MUCOSA; COLON POLYP; COLORECTAL CANCER; CONTROLLED STUDY; DYSPLASIA; HEREDITARY MIXED POLYPOSIS SYNDROME; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; POLYPOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

ADENOMATOUS POLYPOSIS COLI; CYCLOOXYGENASE 2; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 13644262221     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-004-9591-2     Document Type: Article

References (29)

1. Jaeger EEM, Woodford-Richens KL, Lockett M, Rowan AJ, Sawyer EJ, Heinimann K, Rozen P, Murday VA, Whitelaw SC, Ginsberg A, Atkin WS, Lynch HT, Southey MC, Debinski H, Eng C, Bodmer WF, Talbot IC, Hodgson SV, Thomas HJW, Tomlinson IPM: An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with Hereditary Mixed Polyposis Syndrome. Am J Hum Genet 72:1261-1267, 2003
2. Rozen P, Samuel Z, Brazowski E: A prospective study of the clinical, genetic, screening and pathological features of a family with hereditary mixed polyposis syndrome. Am J Gastroenterol 98:2317-2320, 2003
3. Steinbach G, Lynch PM, Philips RKS, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK, Levin B: The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342:1946-1952, 2000
4. Rossi DJ, Ylikorkala A, Korsisaari N, Salovaara R, Luukko K, Launonen V, Henkemeyer, Ristimäki A, Aaltonen LA, Mäkelä TP: Induction of cyclooxygenase-2 in a mouse model of Peutz-Jegher polyposis. Proc Natl Acad Sci USA 99:12327-12332, 2002
5. McGarrity TJ, Peiffer LP, Amos CI, Frazier ML, Ward MG, Howett MK: Overexpression of cyclooxygenase 2 in hamartomatous polyps of Peutz-Jeghers Syndrome. Am J Gastroenterol 98:671-678, 2003
6. Rozen P, Samuel Z, Brazowski E, Jakubowicz M, Rattan J, Halpern Z: An audit of familial juvenile polyposis at the Tel Aviv Medical Center: demographic, genetic and clinical features. Fam Cancer 2:1-7, 2003
7. Sonoshita M, Takaku K, Oshima M, Sugihara K, Taketo MM: Cyclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps. Cancer Res 62:6846-6849, 2002
8. Takeda H, Sonoshita M, Oshima H, Sugihara K-I, Chulada PC, Langenbach R, Oshima M, Taketo MM: Cooperation of cyclooxygenase 1 and cyclooxygenase 2 in intestinal polyposis. Cancer Res 63:4872-4877, 2003
9. Kune GA, Kune S, Watson LF: Colorectal cancer risk, chronic illnesses, operations, and medications: Case control results from the Melbourne Colorectal Cancer Study. Cancer Res 48:4399-4404, 1988
10. Thun MJ, Namboodiri MM, Heath CW Jr: Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325:1593-1596, 1991
11. Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztess R, Petrelli N, Pipas JM, Karp DD, Loprinzi CL, Steinbach G, Schilsky R: A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 348:883-890, 2003
12. Benamouzig R, Deyra J, Martin A, Girard B, Julian E, Piednoir B, Couturier D, Coste T, Little J, Chaussade S, for The Association Pour La Prevention Par L'Aspirine due Cancer Colorectal Study Group: Daily soluble aspirin and prevention of colorectal adenoma recurrence: One-year results of the APACC trial. Gastroenterology 125:328-336, 2003
13. Sørensen HT, Friis S, Nørgård B, Mellemkjær L, Blot WJ, McLaughlin JK, Ekbom A, Baron JA: Risk of cancer in a large cohort of nonaspirin NSAID users: A population-based study. Br J Cancer 88:1687-1692, 2003
14. Arao J, Sano Y, Fujii T, Shigeharu K, Fu KI, Yoshino T, Ochiai A, Fujimori T, Yoshida S: Cyclooxygenase-2 is overexpressed in serrated adenoma of the colorectum. Dis Colon Rectum 44:1319-1323, 2001
15. Takeuchi M, Kobayashi M, Ajioka Y, Honma T, Suzuki Y, Azumaya M, Narisawa R, Hayashi S-I, Asakura H: Comparison of cyclo-oxygenase 2 expression in colorectal serrated adenomas to expression in tubular adenomas and hyperplastic polyps. Int J Colorectal Dis 17:144-149, 2002
16. Kawada M, Seno H, Wada M, Suzuki K, Kanda N, Kayahara T, Fukui H, Sawada M, Kajiyama T, Sakai M, Chiba T: Cyclooxygenase-2 expression and angiogenesis in gastric hyperplastic polyp - Association with polyp size. Digestion 67:20-24, 2003
17. Chapple KS, Cartwright EJ, Hawcroft G, Tisbury A, Bonifer C, Scott N, Windsor ACJ, Guillou PJ, Markham AF, Coletta PL, Hull MA: Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am J Pathol 156:545-553, 2000
18. Sato T, Yoshinaga K, Okabe S, Enomoto M, TakizawaT, Sugihara K: Cyclooxygenase-2 expression in colorectal adenomas. Dis Colon Rectum 46:786-792, 2003
19. Einspahr JG, Krouse RS, Yochim JM, Danenberg PV, Danenberg KD, Bhattacharyya AK, Martínez ME, Alberts DS: Association between cyclooxygenase expression and colorectal adenoma characteristics. Cancer Res 63:3891-3893, 2003
20. Bamba H, Ota S, Kato A, Adachi, A, Itoyama S, Matsuzaki F: High expression of cyclooxygenase-2 in macrophages of human colonic adenoma. Int J Cancer 83:470-475, 1999
21. Yamauchi T, Watanabe M, Kubota T, Hasegawa H, Yoshiyuki I, Endo T, Kabeshima Y, Yorozuya K, Yamamoto K, Mukai M, Kitajima M: Cyclooxygenase-2 expression as a new marker for patients with colorectal cancer. Dis Colon Rectum 45:98-103, 2002
22. Garewal H, Ramsey L, Fass R, Hart NK, Payne CM, Berstein H, Bernstein C: Perils of immunohistochemistry. Dig Dis Sci 48:197-202, 2003
23. Ohno S, Suzuki N, Ohno Y, Inagawa H, Soma G-I, Inoue M: Tumor-associated macrophages: Foc or accomplice of tumors? Anticancer Res 23:4395-4410, 2003
24. Balkwill F, Mantovani A: Inflammation and cancer: Back to Virchow? Lancet 357:539-545, 2001
25. Sica A, Saccani A, Mantovani A: Tumor-associated macrophages: A molecular perspective. Int Immunopharmacol 2:1045-1054, 2002
26. Ladabaum U, Scheiman JM, Fendrick AM: Potential effect of cyclooxygenase-2-specific inhibitors on the prevention of colorectal cancer: a cost-effectiveness analysis. Am J Med 114:546-554, 2003
27. Cruz-Correa M, Hylind LM, Romans KE, Booker SV, Giardiello FM: Long-term treatment with sulindac in familial adenomatous polyposis: A prospective cohort study. Gastroenterology 122:641-645, 2002
28. Rüschoff J, Wallinger S, Dietmaier W, Bocker T, Brockhoff G, Hofstädter F, Fishel R: Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection. Proc Natl Acad Sci 95:11301-11306, 1998
29. Azumaya M, Kobayashi M, Ajioka Y, Honma T, Suzuki Y, Takeuchi M, Narisawa R, Asakura H: Size-dependent expression of cyclooxygenase-2 in sporadic colorectal adenomas relative to adenomas in patients with familial adenomatous polyposis. Pathology Int 52:272-276, 2002